AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16753387
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium diet (1,000 mg daily)
Trial: 16753387
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium diet (400 mg daily)
Trial: 14749743
Drug: Elderberry juice
RxNorm normalized name: EUROPEAN ELDERBERRY JUICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elderberry juice (400 mg spray-dried powder containing 10% anthocyanes t.i.d. equivalent to 5 ml elderberry juice for 2 weeks)
Trial: 14749743
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of elderberry juice (50 ml) along with a high-fat breakfast
Trial: 55029
Drug: Subcutaneous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous low-dose heparin prophylaxis
Trial: 55029
Drug: Sodium and
RxNorm normalized name: Sodium and/or sodium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium and calcium heparin administered subcutaneously
Trial: 26305649
Drug: Long-chain polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-chain polyunsaturated fatty acids (LCPUFAs) (1 g)
Trial: 26305649
Drug: Lutein (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein (10 mg)/zeaxanthin (2 mg)
Trial: 22054797
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR (400-800 mg once daily)
Trial: 10997497
Drug: Penciclovir 1%
RxNorm normalized name: PENCICLOVIR 1% CREAM.TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penciclovir 1% cream applied 5 times daily for up to 7 days
Trial: 10997497
Drug: Acyclovir 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 3% cream
Trial: 1484177
Drug: Sertraline (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50-200 mg/day for 8 weeks)
Trial: 1484177
Drug: Sertraline (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50, 100, or 200 mg/day for 12 weeks)
Trial: 6382103
Drug: Doxium (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxium (calcium dobesilate) 1,500 mg daily for 3 months
Trial: 31250356
Drug: Broccoli sprout
RxNorm normalized name: BROCCOLI SPROUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprout supplementation (15 capsules daily containing 90 mg sulforaphane and 180 mg glucoraphanin)
Trial: 27340991
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injections (16 mg/mL)
Trial: 25403207
Drug: Extended rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Extended rituximab exposure (375 mg/m²) with 6×R‐CHOP‐14 (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone on a 14-day schedule)
Trial: 22522725
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (n = 24)
Trial: 19244175
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Selenium and Vitamin E
Trial: 15115902
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of bimakalim (0.1, 0.3 or 0.6 mg)
Trial: 15115902
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of bimakalim (0.025 or 0.05 mg)
Trial: 15115902
Drug: Bimakalim (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimakalim (both high and low doses)
Trial: 9853633
Drug: State model
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: State model (consultation about new or changed prescriptions)
Trial: 7865090
Drug: 0.3% triclosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3% triclosan (topical application)
Trial: 2573298
Drug: Procaterol high
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol high dose (0.01 mg/inhalation, two inhalations, three times daily)
Trial: 2573298
Drug: Procaterol low
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol low dose (0.01 mg/inhalation, one inhalation, three times daily)
Trial: 4605401
Drug: A2/HK/68 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A2/HK/68 vaccine
Trial: 4605401
Drug: B/Mass/66 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B/Mass/66 vaccine
Trial: 4605401
Drug: Bivalent vaccine
RxNorm normalized name: PAPILLOMAVIRUS BIVALENT VACCINE INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent vaccine (B/Mass/66 and A2/Mtl/68)
Trial: 4605401
Drug: Standard aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard aqueous killed bivalent vaccine
Trial: 4605401
Drug: Zonally-purified vaccines
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zonally-purified vaccines
Trial: 31000205
Drug: 2-dimensional treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-dimensional treatment planning
Trial: 31000205
Drug: 3-dimensional treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-dimensional treatment planning
Trial: 26374833
Drug: Ketoacid supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoacid supplementation (12 tablets per day)
Trial: 21525519
Drug: Lithium (0.25-0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (0.25-0.5 mmol/l), n = 24
Trial: 19252768
Drug: Periarterial infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periarterial infiltration of 3-5 ml of saline around scalp arteries
Trial: 15521369
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of rofecoxib
Trial: 1492862
Drug: Dihydroergocristine (DHEC)
RxNorm normalized name: Dihydroergocristine
DrugBank: Dihydroergocristine (DB13345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergocristine (DHEC) 6 mg once daily
Trial: 4023162
Drug: Estrogen-androgen combined
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen-androgen combined preparation
Trial: 4023162
Drug: Estrogen-alone drug
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen-alone drug
Trial: 4023162
Drug: Androgen-alone drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen-alone drug
Trial: 27755279
Drug: Open-label placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label placebo (OLP) treatment after switch from TAU
Trial: 23683464
Drug: Bronchodilator response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bronchodilator response (BDR) test with a cutoff of 12%
Trial: 23683464
Drug: Bronchodilator response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bronchodilator response (BDR) test with a cutoff of less than 8%
Trial: 20949229
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (BiPAP and standard oxygen therapy)
Trial: 6770498
Drug: Antimicrobial prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial prophylaxis (oral nonabsorbed antibiotics)
Trial: 6770498
Drug: Parenteral administration
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral administration of antibiotics
Trial: 30957578
Drug: Alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-lipoic acid (ALA) 600 mg
Trial: 30957578
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid 250 mg
Trial: 30957578
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ALA and mefenamic acid
Trial: 16498052
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet (LF) - 0.5 g fat/kg body weight (BW) per day for 2.5 days
Trial: 16498052
Drug: High-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat diet (HF) - 0.5 g fat/kg BW per day for 1 day followed by 3.5 g fat/kg BW per day for 1.5 days
Trial: 15007562
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow injection (15 ml) at the fracture site and casting
Trial: 9836064
Drug: Panicogenic doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panicogenic doses of caffeine administered to PD patients
Trial: 9836064
Drug: Panicogenic doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panicogenic doses of caffeine administered to healthy volunteers
Trial: 7659767
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (2-mg pieces, up to 30 per day) with reinforcement of lottery tickets for CO < 10 ppm
Trial: 6807878
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg erythromycin ethyl succinate intramuscularly
Trial: 6807878
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg erythromycin stearate orally
Trial: 30885685
Drug: AG10 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG10 400 mg
Trial: 30885685
Drug: AG10 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG10 800 mg
Trial: 29935541
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual + training of the GP (intervention group)
Trial: 26024926
Drug: Polyethylene glycol‐electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol‐electrolyte oral solution (PEG‐EOS)
Trial: 2193839
Drug: Frusemide/amiloride (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide/amiloride (20 mg frusemide/2.5 mg amiloride daily)
Trial: 2193839
Drug: Bumetanide/potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide/potassium chloride (0.5 mg bumetanide/573 mg potassium chloride daily)
Trial: 30580092
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (clopidogrel and low-dose aspirin)
Trial: 19994684
Drug: Routine western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine western medicine (Metoprolol, Propafenone, Aspirin)
Trial: 11727735
Drug: Trinam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trinam (1 x 10^11 viral particles, single administration)
Trial: 7506187
Drug: Nimesulide 800mg
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 800mg daily
Trial: 7506187
Drug: Nimesulide 400mg
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 400mg daily
Trial: 7506187
Drug: Nimesulide 600mg
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 600mg daily
Trial: 7506187
Drug: Nimesulide 200mg
RxNorm normalized name: nimesulide 200 MG
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 200mg daily
Trial: 7506187
Drug: Nimesulide 300mg
DrugBank: Nimesulide (DB04743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 300mg daily
Trial: 2882234
Drug: Peripheral intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral intravenous adrenaline
Trial: 28889834
Drug: Interviewer-administered dietary
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interviewer-administered dietary recalls
Trial: 25310993
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Lupron Depot (22.5 mg leuprolide acetate)
Trial: 25310993
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Lupron Depot (11.25 mg leuprolide acetate)
Trial: 23452187
Drug: BCG induction
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG induction therapy or BCG induction plus maintenance
Trial: 17611132
Drug: Zafirlukast (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast (40 mg orally the evening before and 40 mg the morning of assessment)
Trial: 12883229
Drug: Gabapentin (GBP)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (GBP) 1800 mg/d
Trial: 12883229
Drug: Vigabatrin (VGB)
DrugBank: Vigabatrin (DB01080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vigabatrin (VGB) 1000 mg/d
Trial: 10969365
Drug: Pre MB
RxNorm normalized name: Ionosol-MB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre MB (morphine and bupivacaine)
Trial: 10969365
Drug: Pre M
RxNorm normalized name: Pre Milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre M (morphine)
Trial: 10969365
Drug: Post MB
RxNorm normalized name: Ionosol-MB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post MB (morphine and bupivacaine)
Trial: 1451724
Drug: O-(beta-hydroxyethyl)-rutosides (HR)
RxNorm normalized name: Padimate O
DrugBank: Padimate O (DB11570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: O-(beta-hydroxyethyl)-rutosides (HR) 2 x 1.5 g IV before surgery
Trial: 6396153
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral co-trimoxazole
Trial: 6396153
Drug: Five-day oral
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-day oral co-trimoxazole
Trial: 30807389
Drug: Microneedling followed
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microneedling followed by PMMA-collagen gel filler
Trial: 8435171
Drug: Preoperative steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative steroid treatment (methylprednisolone)
Trial: 8435171
Drug: Postoperative steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative steroid treatment (methylprednisolone)
Trial: 8435171
Drug: SK&F 86002
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK&F 86002 (nonsteroidal dual cyclooxygenase/lipooxygenase inhibitor)
Trial: 8435171
Drug: Delayed steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed steroid administration
Trial: 8435171
Drug: Preoperative steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative steroid therapy (in double-blinded placebo-controlled study)
Trial: 3304117
Drug: Verapamil (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (360 mg/24 h)
Trial: 3304117
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg/24 h)
Trial: 24013685
Drug: Baseline UPCR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline UPCR < 1.0 g/gCr
Trial: 24013685
Drug: Residual UPCR
RxNorm normalized name: antihemophilic factor, human recombinant residues 743-1636 deleted Injection [Xyntha]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Residual UPCR ≥ 1.0 g/gCr and ΔUPCR <30%
Trial: 20805623
Drug: Low-dose unfractionated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose unfractionated heparin, 50 U/kg
Trial: 20805623
Drug: Standard-dose unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose unfractionated heparin, 85 U/kg (60 U/kg with GpIIb‐IIIa inhibitors)
Trial: 16760927
Drug: Risperidone augmentation
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone augmentation (0.25-2.0 mg/day)
Trial: 16760927
Drug: Risperidone augmentation
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone augmentation (0.25-2.0 mg/day) in fully nonresponsive patients
Trial: 16760927
Drug: Placebo augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo augmentation in fully nonresponsive patients
Trial: 9663833
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ABT-229
Trial: 9663833
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg ABT-229
Trial: 3527181
Drug: suprofen syrup
RxNorm normalized name: Suprofen
DrugBank: Suprofen (DB00870)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: suprofen syrup 10 mg/ml
Trial: 21490622
Drug: Successful anti-hypertensive
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful anti-hypertensive treatment
Trial: 20954414
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy and kinesy-therapy
Trial: 20954414
Drug: Interferential current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential current and kinesy-therapy
Trial: 18296423
Drug: Ixabepilone 6
RxNorm normalized name: Ixabepilone
DrugBank: Ixabepilone (DB04845)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ixabepilone 6 mg/m(2)/day x 5 days every 21 days (arm A)
Trial: 18296423
Drug: Ixabepilone 20
RxNorm normalized name: Ixabepilone
DrugBank: Ixabepilone (DB04845)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ixabepilone 20 mg/m(2) on days 1, 8, and 15 of a 28-day cycle (arm B)
Trial: 18296423
Drug: Weekly ixabepilone
RxNorm normalized name: Ixabepilone
DrugBank: Ixabepilone (DB04845)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly ixabepilone 20 mg/m(2)
Trial: 14765564
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral treatment system
Trial: 8886909
Drug: Methylprednisolone (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (2000 mg 2‐3 hours before cisplatin)
Trial: 1303780
Drug: cyclosporin A,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclosporin A, daily dose of 100 mg for 2 years
Trial: 24694205
Drug: Low vitamin
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low vitamin B12 group (B12 < 221 pmol/l)
Trial: 22566538
Drug: Iron plus
RxNorm normalized name: Nu-Iron Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron plus folic acid (12.5 mg of iron and 50 μg of folic acid)
Trial: 18565127
Drug: Metformin 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1500 or 2550 mg/day for 8 months
Trial: 10609921
Drug: DCLHb as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCLHb as an adjunct to standard therapy
Trial: 1657502
Drug: Capsaicin inhalation
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin inhalation at 50 litres/min
Trial: 1657502
Drug: Capsaicin inhalation
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin inhalation at 100 litres/min
Trial: 1657502
Drug: Citric acid
RxNorm normalized name: Citric Acid
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citric acid inhalation at 50 litres/min
Trial: 6355047
Drug: Acyclovir low
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir low dose (5 mg/kg every 8 h)
Trial: 6355047
Drug: Acyclovir high
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir high dose (500 mg/m2 every 8 h)
Trial: 31665746
Drug: Micronutrient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient treatment (up to 12 capsules/day)
Trial: 16220331
Drug: Ketamine (60-min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (60-min infusion)
Trial: 8528821
Drug: Outpatient, once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient, once a week group treatment for sexually abused girls
Trial: 2222351
Drug: Nasal histamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal histamine (maximum nasal dose of 250 micrograms)
Trial: 31910803
Drug: Home-based computerized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based computerized executive function training programme (12 weeks, 5 days a week, 30 min a day training, total dose = 30 h)